CoChat

Acetylation of MAT IIα represses tumour cell growth and is decreased in human hepatocellular cancer

Open access
Yang, Hong-Bin, Xu, Ying-Ying, Zhao, Xiang-Ning, Zou, Shao-Wu, Zhang, Ye, Zhang, Min, Li, Jin-Tao, Ren, Feng, Wang, Li-Ying, Lei, Qun-Ying · 2015 · Nature Communications

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Metabolic alteration is a hallmark of cancer. Dysregulation of methionine metabolism is implicated in human liver cancer. Methionine adenosyltransferase IIα (MAT IIα) is a key enzyme in the methionine cycle, catalysing the production of S-adenosylmethionine (SAM), a key methyl donor in cellular processes, and is associated with uncontrolled cell proliferation in cancer. Here we show that P300 acetylates MAT IIα at lysine residue 81 and destabilizes MAT IIα by promoting its ubiquitylation and subsequent proteasomal degradation. Conversely, histone deacetylase-3 deacetylates and stabilizes MAT IIα by preventing its proteasomal degradation. Folate deprivation upregulates K81 acetylation and destabilizes MAT IIα to moderate cell proliferation, whereas a single mutation at K81 reverses the proliferative disadvantage of cancer cells upon folate deprivation. Moreover, MAT IIα K81 acetylation is decreased in human hepatocellular cancer. Collectively, our study reveals a novel mechanism of MAT IIα regulation by acetylation and ubiquitylation, and a direct functional link of this regulation to cancer development.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms7973

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 MAT IIα is acetylated at lysine 81. (a) Exogenous MAT IIα is acetylated. Flag-MAT IIα was transfected into HEK293T and Chang's cells followed by TSA treatment (10 μM) for 18 h. Flag-MAT IIα acetylation was detected by anti-acetyllysine (Pan-Ac) antibody. (b) Alignment of MAT IIα lysine 81 and adjacent protein sequence from different organisms. Hs: Homo Sapient (human); Pt: Pan troglodytes (chimpanzee); Cl: Canis lupus familiaris (dog); Bt: Bos taurus (bull); Mm: Mus musculus (mouse); Rn: Rattus norvegicus (Norway rat); Dm: Drosophila melanogaster (fruit fly). (c) TSA increases acetylation level of wild-type MAT IIα but not mutants. Ectopically expressed wild-type MAT IIα, K81R and K81Q were transfected into HEK293T cells followed by TSA treatment, MAT IIα acetylation was analysed by western blotting. (d) Specificity of K81 site-specific acetylation antibody was determined by dot blotting assay. (e) MAT2A knockdown confirmed the K81Ac antibody detection. HEK293T cells were transfected with MAT2A siRNA or scramble control and cell lysates were subjected to western blotting. Signal detected by K81Ac antibody decreased as MAT IIα was knocked down. (f) K81Ac antibody is specific to MAT IIα K81 acetylation. HEK293T cells were lysed and directly subjected to western blotting. The four repetitively loaded lanes were clipped into four membranes and were exposed to antibodies as indicated, separately. For peptide block, acetylated K81 peptide (the antigen we used for K81Ac antibody generation) or non-acetylated K81 peptide (mimicking MAT IIα protein) were added to the diluted K81Ac antibodies (1:200) in a final concentration of 300 μg ml-1, cultivated at 37 °C for 1 h before applying to membranes. Four clipped membranes were aligned and exposed together when developing film to make sure their relative signal intensities are comparable. (g) TSA promotes MAT IIα acetylation at K81 in different cell lines. HEK293T, Hela and HepG2 cells were treated as indicated. K81 acetylation was detected by K81Ac antibody and normalized against MAT IIα protein.
Figure 1 MAT IIα is acetylated at lysine 81. (a) Exogenous MAT IIα is acetylated. Flag-MAT IIα was transfected into HEK293T and Chang's cells followed by TSA treatment (10 μM) for 18 h. Flag-MAT IIα acetylation was detected by anti-acetyllysine (Pan-Ac) antibody. (b) Alignment of MAT IIα lysine 81 and adjacent protein sequence from different organisms. Hs: Homo Sapient (human); Pt: Pan troglodytes (chimpanzee); Cl: Canis lupus familiaris (dog); Bt: Bos taurus (bull); Mm: Mus musculus (mouse); Rn: Rattus norvegicus (Norway rat); Dm: Drosophila melanogaster (fruit fly). (c) TSA increases acetylation level of wild-type MAT IIα but not mutants. Ectopically expressed wild-type MAT IIα, K81R and K81Q were transfected into HEK293T cells followed by TSA treatment, MAT IIα acetylation was analysed by western blotting. (d) Specificity of K81 site-specific acetylation antibody was determined by dot blotting assay. (e) MAT2A knockdown confirmed the K81Ac antibody detection. HEK293T cells were transfected with MAT2A siRNA or scramble control and cell lysates were subjected to western blotting. Signal detected by K81Ac antibody decreased as MAT IIα was knocked down. (f) K81Ac antibody is specific to MAT IIα K81 acetylation. HEK293T cells were lysed and directly subjected to western blotting. The four repetitively loaded lanes were clipped into four membranes and were exposed to antibodies as indicated, separately. For peptide block, acetylated K81 peptide (the antigen we used for K81Ac antibody generation) or non-acetylated K81 peptide (mimicking MAT IIα protein) were added to the diluted K81Ac antibodies (1:200) in a final concentration of 300 μg ml-1, cultivated at 37 °C for 1 h before applying to membranes. Four clipped membranes were aligned and exposed together when developing film to make sure their relative signal intensities are comparable. (g) TSA promotes MAT IIα acetylation at K81 in different cell lines. HEK293T, Hela and HepG2 cells were treated as indicated. K81 acetylation was detected by K81Ac antibody and normalized against MAT IIα protein.CC BY · PubMed Central
Figure 2 Folate decreases K81 acetylation and stabilizes MAT IIα. (a) Folate deprivation increases K81 acetylation of MAT IIα and decreases its protein level. HEK293T cells were cultured in medium containing folate of different concentrations as indicated for 48 h. Western blotting was used to determine MAT IIα protein and K81 acetylation levels. (b) Folate-deprivation has no effect on MAT2A mRNA level. MAT2A mRNA was determined by qPCR and normalized against β-actin. Error bars represent ±s.d. of triplicate experiments. The two-tailed Student's t-test was used. NS denotes no significance. (c) MG132 rescues the decrease in MAT IIα protein induced by folate deprivation. HEK293T cells were cultured as indicated and treated with either dimethylsulphoxide (DMSO; solvent) or 10 μM MG132 for 6 h. Cell lysates were analysed by western blotting. (d) Folate deprivation exclusively shortens the half-life of wild-type MAT IIα, but not K81R or K81Q mutant. HEK293 stable cell lines expressing wild-type MAT IIα, or K81R/K81Q mutants were cultured in folate-deprived condition for 48 h, CHX (10 μg ml-1) treatment was applied for different time course before harvest. MAT IIα protein levels were determined by western blotting (left panel). The right panel showcases relative protein amounts of different groups. Error bars represent ±s.d. of triplicate experiments. The two-tailed Student's t-test was used. **P<0.01; ***P<0.001. (e) K81R mutation blocks MAT IIα ubiquitylation induced by TSA. HEK293T cells were transfected with the indicated plasmids. After TSA and MG132 treatment as indicated, ubiquitylation of purified flag-MAT IIα proteins were determined. (f) Folate deprivation promotes ubiquitylation of wild-type MAT IIα but not K81R mutant. HEK293T cells were transfected as indicated. Ubiquitylation of flag-MAT IIα protein was determined by western blotting. (g) MG132 stabilizes MAT IIα upon folate deprivation. HEK293T cells were cultured under normal or folate-deprived condition, followed by CHX and MG132 treatment. Cell lysates were directly subjected to western blotting (left panel). The right panel showcases relative protein amounts of different groups. Error bars represent ±s.d. of triplicate experiments. The two-tailed Student's t-test was used. **P<0.01; ***P<0.001.
Figure 2 Folate decreases K81 acetylation and stabilizes MAT IIα. (a) Folate deprivation increases K81 acetylation of MAT IIα and decreases its protein level. HEK293T cells were cultured in medium containing folate of different concentrations as indicated for 48 h. Western blotting was used to determine MAT IIα protein and K81 acetylation levels. (b) Folate-deprivation has no effect on MAT2A mRNA level. MAT2A mRNA was determined by qPCR and normalized against β-actin. Error bars represent ±s.d. of triplicate experiments. The two-tailed Student's t-test was used. NS denotes no significance. (c) MG132 rescues the decrease in MAT IIα protein induced by folate deprivation. HEK293T cells were cultured as indicated and treated with either dimethylsulphoxide (DMSO; solvent) or 10 μM MG132 for 6 h. Cell lysates were analysed by western blotting. (d) Folate deprivation exclusively shortens the half-life of wild-type MAT IIα, but not K81R or K81Q mutant. HEK293 stable cell lines expressing wild-type MAT IIα, or K81R/K81Q mutants were cultured in folate-deprived condition for 48 h, CHX (10 μg ml-1) treatment was applied for different time course before harvest. MAT IIα protein levels were determined by western blotting (left panel). The right panel showcases relative protein amounts of different groups. Error bars represent ±s.d. of triplicate experiments. The two-tailed Student's t-test was used. **P<0.01; ***P<0.001. (e) K81R mutation blocks MAT IIα ubiquitylation induced by TSA. HEK293T cells were transfected with the indicated plasmids. After TSA and MG132 treatment as indicated, ubiquitylation of purified flag-MAT IIα proteins were determined. (f) Folate deprivation promotes ubiquitylation of wild-type MAT IIα but not K81R mutant. HEK293T cells were transfected as indicated. Ubiquitylation of flag-MAT IIα protein was determined by western blotting. (g) MG132 stabilizes MAT IIα upon folate deprivation. HEK293T cells were cultured under normal or folate-deprived condition, followed by CHX and MG132 treatment. Cell lysates were directly subjected to western blotting (left panel). The right panel showcases relative protein amounts of different groups. Error bars represent ±s.d. of triplicate experiments. The two-tailed Student's t-test was used. **P<0.01; ***P<0.001.CC BY · PubMed Central
Figure 3 UBR4 targets MAT IIα for degradation. (a) UBR4 overexpression decreases MAT IIα protein. HEK293T cells were transfected as indicated (UBR4 (D) represents a truncated form of UBR4 protein, with substrate-binding and catalytic domains only), followed by MG132 treatment. Cell lysates were directly subjected to western blotting. (b) UBR4 knockdown rescues MAT IIα protein reduced by folate deprivation. Three different siRNA oligos siUBR4-1, -2 and -3 were transfected, respectively, or together (siUBR4-T) into HEK293T cells. Protein levels of MAT IIα were determined by western blotting. UBR4 knockdown efficiency was analysed by qPCR. Values were normalized against β-actin and compared with the relative mRNA of folate (1 mg l-1) group (set as 1.0). Error bars represent ±s.d. of triplicate experiments. The two-tailed Student's t-test was used. **P<0.01; ***P<0.001. (c) UBR4 knockdown increases MAT IIα stability. HEK293T cells were transfected with siUBR4 or control. CHX chase experiment was performed and MAT IIα protein was determined by western blotting (left panel). The right panel showcases relative protein amounts of different groups. Error bars represent ±s.d. of triplicate experiments. The two-tailed Student's t-test was used. **P<0.01; ***P<0.001. (d) UBR4 knockdown blocks folate-deprivation induced-ubiquitylation of MAT IIα. HEK293T cells were transfected as indicated and cultured in folate containing or deprived culture medium. Ubiquitylation assay was conducted. The efficiency of UBR4 knockdown was validated by qPCR. Error bars represent ±s.d. of triplicate experiments. The two-tailed Student's t-test was used. ***P<0.001.
Figure 3 UBR4 targets MAT IIα for degradation. (a) UBR4 overexpression decreases MAT IIα protein. HEK293T cells were transfected as indicated (UBR4 (D) represents a truncated form of UBR4 protein, with substrate-binding and catalytic domains only), followed by MG132 treatment. Cell lysates were directly subjected to western blotting. (b) UBR4 knockdown rescues MAT IIα protein reduced by folate deprivation. Three different siRNA oligos siUBR4-1, -2 and -3 were transfected, respectively, or together (siUBR4-T) into HEK293T cells. Protein levels of MAT IIα were determined by western blotting. UBR4 knockdown efficiency was analysed by qPCR. Values were normalized against β-actin and compared with the relative mRNA of folate (1 mg l-1) group (set as 1.0). Error bars represent ±s.d. of triplicate experiments. The two-tailed Student's t-test was used. **P<0.01; ***P<0.001. (c) UBR4 knockdown increases MAT IIα stability. HEK293T cells were transfected with siUBR4 or control. CHX chase experiment was performed and MAT IIα protein was determined by western blotting (left panel). The right panel showcases relative protein amounts of different groups. Error bars represent ±s.d. of triplicate experiments. The two-tailed Student's t-test was used. **P<0.01; ***P<0.001. (d) UBR4 knockdown blocks folate-deprivation induced-ubiquitylation of MAT IIα. HEK293T cells were transfected as indicated and cultured in folate containing or deprived culture medium. Ubiquitylation assay was conducted. The efficiency of UBR4 knockdown was validated by qPCR. Error bars represent ±s.d. of triplicate experiments. The two-tailed Student's t-test was used. ***P<0.001.CC BY · PubMed Central
Figure 4 P300 acetylates MAT IIα. (a) Overexpression of P300, not other HATs, increases acetylation of exogenous MAT IIα. HEK293T cells were transfected as indicated and acetylation of flag-MAT IIα was determined using Pan-Ac antibody. (b) Overexpression of P300 increases K81 acetylation of endogenous MAT IIα. HEK293T cells were transfected with flag-P300 and K81 acetylation of MAT IIα was determined using K81Ac antibody. (c) P300 knockdown decreases MAT IIα K81 acetylation. HEK293T cells were transfected with siP300 or control and MAT IIα acetylation levels were determined by western blotting. (d) P300 decreases protein levels of MAT IIα. Flag-P300 was transfected in declined doses into HEK293T cells and cell lysates were measured by western blotting. (e) P300 knockdown increases MAT IIα stability. HEK293T cells were transfected with siP300 or control and cultured under folate-deprived condition before CHX was added and treated for indicated durations. Levels of endogenous MAT IIα protein were determined by western blotting and normalized against β-actin (left panel). The right panel showcases relative protein amounts of different groups. Error bars represent ±s.d. of triplicate experiments. The two-tailed Student's t-test was used. *P<0.05; **P<0.01; ***P<0.001. (f) Folate-deprivation enhances MAT IIα–P300 interaction. HEK293T cells were transfected with flag-tagged MAT IIα and cultured in normal or folate-deprived conditions. The interaction between flag-MAT IIα and endogenous P300 was determined by co-IP followed by western blotting. (g) P300 acetylates MAT IIα at K81 in vitro. Ectopically expressed GST-MAT IIα from BL21 E. coli was purified through GST antibody-conjugated beads and incubated with P300 (immunoprecipitation-purified and eluted). K81 acetylation levels were analysed using K81Ac antibody and normalized against GST-MAT IIα.
Figure 4 P300 acetylates MAT IIα. (a) Overexpression of P300, not other HATs, increases acetylation of exogenous MAT IIα. HEK293T cells were transfected as indicated and acetylation of flag-MAT IIα was determined using Pan-Ac antibody. (b) Overexpression of P300 increases K81 acetylation of endogenous MAT IIα. HEK293T cells were transfected with flag-P300 and K81 acetylation of MAT IIα was determined using K81Ac antibody. (c) P300 knockdown decreases MAT IIα K81 acetylation. HEK293T cells were transfected with siP300 or control and MAT IIα acetylation levels were determined by western blotting. (d) P300 decreases protein levels of MAT IIα. Flag-P300 was transfected in declined doses into HEK293T cells and cell lysates were measured by western blotting. (e) P300 knockdown increases MAT IIα stability. HEK293T cells were transfected with siP300 or control and cultured under folate-deprived condition before CHX was added and treated for indicated durations. Levels of endogenous MAT IIα protein were determined by western blotting and normalized against β-actin (left panel). The right panel showcases relative protein amounts of different groups. Error bars represent ±s.d. of triplicate experiments. The two-tailed Student's t-test was used. *P<0.05; **P<0.01; ***P<0.001. (f) Folate-deprivation enhances MAT IIα–P300 interaction. HEK293T cells were transfected with flag-tagged MAT IIα and cultured in normal or folate-deprived conditions. The interaction between flag-MAT IIα and endogenous P300 was determined by co-IP followed by western blotting. (g) P300 acetylates MAT IIα at K81 in vitro. Ectopically expressed GST-MAT IIα from BL21 E. coli was purified through GST antibody-conjugated beads and incubated with P300 (immunoprecipitation-purified and eluted). K81 acetylation levels were analysed using K81Ac antibody and normalized against GST-MAT IIα.CC BY · PubMed Central
Figure 5 HDAC3 deacetylates MAT IIα. (a) Overexpression of HDAC3, but not other HDACs, decreases the acetylation level of MAT IIα. Each of the HA-tagged HDAC1-7 was co-transfected with flag-tagged MAT IIα into HEK293T cells and the acetylation levels of MAT IIα were determined by standard western blotting. (b) HDAC3 decreases K81 acetylation of endogenous MAT IIα. HEK293T cells were transfected with HA-HDAC3. MAT IIα K81 acetylation was detected using K81Ac antibody. (c) HDAC3 knockdown decreases MAT IIα protein. HEK293T cells were transfected with siHDAC3 or control. Cells were harvested 48 h after transfection, and lysates were analysed by western blotting. (d) HDAC3 knockdown destabilizes MAT IIα. HEK293T cells were transfected with siHDAC3 or control, respectively. CHX chase treatment was applied as indicated. Cell lysates were directly subjected to western blotting (upper panel) and normalized against β-actin. The lower panel showcases relative protein amounts of different groups. Error bars represent ±s.d. of triplicate experiments. The two-tailed Student's t-test was used. **P<0.01; ***P<0.001. (e) Folate increases the interaction between HDAC3 and MAT IIα. HEK293T cells were cultured with or without folate for 48 h and treated with MG132 for 6 h before harvest. Interaction between endogenous MAT IIα and HDAC3 was determined by co-IP and western blotting. (f) GST-MAT IIα can readily pull-down P300 and HDAC3. BL21 E. coli transformed with pGEX-GST-MAT IIα plasmid was induced (or not induced) by isopropyl-β-D-thiogalactoside. Protein was then purified through GST antibody-conjugated column and incubated with HEK293T cell lysates (lysed by 0.3% Nonidet P40 buffer) before re-purified through immunoprecipitation and subjected to western blotting.
Figure 5 HDAC3 deacetylates MAT IIα. (a) Overexpression of HDAC3, but not other HDACs, decreases the acetylation level of MAT IIα. Each of the HA-tagged HDAC1-7 was co-transfected with flag-tagged MAT IIα into HEK293T cells and the acetylation levels of MAT IIα were determined by standard western blotting. (b) HDAC3 decreases K81 acetylation of endogenous MAT IIα. HEK293T cells were transfected with HA-HDAC3. MAT IIα K81 acetylation was detected using K81Ac antibody. (c) HDAC3 knockdown decreases MAT IIα protein. HEK293T cells were transfected with siHDAC3 or control. Cells were harvested 48 h after transfection, and lysates were analysed by western blotting. (d) HDAC3 knockdown destabilizes MAT IIα. HEK293T cells were transfected with siHDAC3 or control, respectively. CHX chase treatment was applied as indicated. Cell lysates were directly subjected to western blotting (upper panel) and normalized against β-actin. The lower panel showcases relative protein amounts of different groups. Error bars represent ±s.d. of triplicate experiments. The two-tailed Student's t-test was used. **P<0.01; ***P<0.001. (e) Folate increases the interaction between HDAC3 and MAT IIα. HEK293T cells were cultured with or without folate for 48 h and treated with MG132 for 6 h before harvest. Interaction between endogenous MAT IIα and HDAC3 was determined by co-IP and western blotting. (f) GST-MAT IIα can readily pull-down P300 and HDAC3. BL21 E. coli transformed with pGEX-GST-MAT IIα plasmid was induced (or not induced) by isopropyl-β-D-thiogalactoside. Protein was then purified through GST antibody-conjugated column and incubated with HEK293T cell lysates (lysed by 0.3% Nonidet P40 buffer) before re-purified through immunoprecipitation and subjected to western blotting.CC BY · PubMed Central
Figure 6 K81 mutations promote tumour cell growth in vitro and in vivo. (a) Verification of HepG2 stable cell lines. Knockdown efficiency and re-expression levels of wild-type or K81R/Q mutants were determined by western blotting. (b) K81R and K81Q mutations reverse the proliferative disadvantage of HepG2 cells upon folate deprivation. HepG2 stable cell characterized in a were cultured in normal or folate-deprived medium. Direct cell count was performed every 24 h after seeding. Error bars represent cell numbers±s.d. for triplicate experiments. The two-tailed Student's t-test was used. **P<0.01; ***P<0.001. (c,d) K81R and K81Q mutants promote xenograft tumour growth. Subcutaneous xenograft experiment was performed in nude mice using HepG2 stable cells. Major and minor diameters of tumours were measured and tumour volumes were calculated. The two-tailed Student's t-test was used. *P<0.05; **P<0.01; ***P<0.001; NS denotes no significance (c). 25 days after injection, tumours were dissected, photographed and weighted. The two-tailed Student's t-test was used. **P<0.01; NS denotes no significance (d). (e) The expression of wild-type, K81R and K81Q MAT IIα in xenografts. Whole-cell lysates were prepared from either original HepG2 stable cell lines or xenograft tumours, followed by western blotting analysis. (f) The hepatocellular cancer clinical samples show an inverse correlation between MAT IIα protein and K81 acetylation. Human hepatocellular cancer samples each paired with cancerous tissue (designated as C) and adjacent normal tissue (designated as N) were lysed and directly subjected to western blotting. Only eight pairs of samples showcasing inverse correlation are shown. For more samples, please refer to supplementary Fig. 6f. (g) Working model. By enhancing MAT IIα association with P300 and UBR4, folate deprivation promotes both MAT IIα K81 acetylation and ubiquitylation, resulting in its proteasomal degradation. Folate stabilizes MAT IIα by dissociating MAT IIα-P300-UBR4 complex, and promoting MAT IIα–HDAC3 interaction. Accumulated MAT II α protein facilitates rapid cell proliferation and, therefore, promotes tumour growth.
Figure 6 K81 mutations promote tumour cell growth in vitro and in vivo. (a) Verification of HepG2 stable cell lines. Knockdown efficiency and re-expression levels of wild-type or K81R/Q mutants were determined by western blotting. (b) K81R and K81Q mutations reverse the proliferative disadvantage of HepG2 cells upon folate deprivation. HepG2 stable cell characterized in a were cultured in normal or folate-deprived medium. Direct cell count was performed every 24 h after seeding. Error bars represent cell numbers±s.d. for triplicate experiments. The two-tailed Student's t-test was used. **P<0.01; ***P<0.001. (c,d) K81R and K81Q mutants promote xenograft tumour growth. Subcutaneous xenograft experiment was performed in nude mice using HepG2 stable cells. Major and minor diameters of tumours were measured and tumour volumes were calculated. The two-tailed Student's t-test was used. *P<0.05; **P<0.01; ***P<0.001; NS denotes no significance (c). 25 days after injection, tumours were dissected, photographed and weighted. The two-tailed Student's t-test was used. **P<0.01; NS denotes no significance (d). (e) The expression of wild-type, K81R and K81Q MAT IIα in xenografts. Whole-cell lysates were prepared from either original HepG2 stable cell lines or xenograft tumours, followed by western blotting analysis. (f) The hepatocellular cancer clinical samples show an inverse correlation between MAT IIα protein and K81 acetylation. Human hepatocellular cancer samples each paired with cancerous tissue (designated as C) and adjacent normal tissue (designated as N) were lysed and directly subjected to western blotting. Only eight pairs of samples showcasing inverse correlation are shown. For more samples, please refer to supplementary Fig. 6f. (g) Working model. By enhancing MAT IIα association with P300 and UBR4, folate deprivation promotes both MAT IIα K81 acetylation and ubiquitylation, resulting in its proteasomal degradation. Folate stabilizes MAT IIα by dissociating MAT IIα-P300-UBR4 complex, and promoting MAT IIα–HDAC3 interaction. Accumulated MAT II α protein facilitates rapid cell proliferation and, therefore, promotes tumour growth.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 66

Metadata

Authors
Yang, H.-B., Xu, Y.-Y., Zhao, X.-N., Zou, S.-W., Zhang, Y., Zhang, M., Li, J.-T., Ren, F., Wang, L.-Y., & Lei, Q.-Y.
Affiliations
  • Shanghai Medical College of Fudan University (CN)
  • Fudan University (CN)
Corresponding author
Lei, Qun-Ying
Venue
Nature Communications
Published
2015-04-30
Volume
6
Issue
1
Pages
6973-6973
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2055346969
Cited by
65
References
25
Citations by year
2026: 3 · 2025: 4 · 2024: 6 · 2023: 4 · 2022: 10 · 2021: 4 · 2020: 7 · 2019: 3 · 2018: 6 · 2017: 8 · 2016: 9 · 2015: 1
FWCI
3.47
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
  • Shanghai Key Basic Research Program (12JC1401100)
  • National Natural Science Foundation of China (81430057, 31271454, 81225016)
  • Fudan University
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer-related gene regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Health Sciences › Nursing › Nutrition and Dietetics › Folate and B Vitamins Research
Keywords
protein acetylation, P300, HDAC3, ubiquitination, proteasomal degradation, S-adenosylmethionine, methionine metabolism, hepatocellular carcinoma, tumor cell proliferation
MeSH terms
Histone Deacetylase 3, Acetylation, Animals, Folic Acid, Carcinoma, Hepatocellular, Histone Deacetylases, Humans, Liver Neoplasms, Male, Methionine Adenosyltransferase, Mice, Nude, Gene Expression Regulation, Neoplastic, Cell Line, Tumor, E1A-Associated p300 Protein, Ubiquitination, Hep G2 Cells, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Acetylation of MAT IIα represses tumour cell growth and is decreased in human hepatocellular cancer. https://app.cochat.ai/papers/10.1038/ncomms7973
The paper
Yang, H.-B., Xu, Y.-Y., Zhao, X.-N., Zou, S.-W., Zhang, Y., Zhang, M., Li, J.-T., Ren, F., Wang, L.-Y., & Lei, Q.-Y. (2015). Acetylation of MAT IIα represses tumour cell growth and is decreased in human hepatocellular cancer. Nature Communications. https://doi.org/10.1038/ncomms7973

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.